1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Crump, M.P.
Elisseeva, E.
Gong, J.-H.
Clark-Lewis, I.
Sykes, B.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
489
171
10.1016/S0014-5793(00)02393-0
11165244
Structure/Function of Human Herpesvirus-8 Mip-II (1-71) and the Antagonist N-Terminal Segment (1-10)
2001
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
8142.661
VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
RESIDUES 1-71
1
syn
polymer
VMIP-II, VMIP-1B
no
no
LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR
LGASWHRPDKCCLGYQKRPLPQVLLSSWYPTSQLCSKPGVIFLTKRGRQVCADKSKDWVKKLMQQLPVTAR
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
repository
Initial release
Version format compliance
Version format compliance
1
0
2001-01-07
1
1
2011-05-08
1
2
2011-07-13
NMR SOLUTION STRUCTURES OF THE VMIP-II 1-10 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS. (RESIDUES 1-10 55 STRUCTURES)
CRYSTAL STRUCTURE OF VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
STRUCTURE OF THE ANTI-HIV CHEMOKINE VMIP-II
PDBE
Y
PDBE
2000-12-01
REL
37296
HUMAN HERPESVIRUS 8
sample
SEE PAPER FOR FURTHER EXPERIMENTAL DETAILS.
1
1
DQF-COSY
TOCSY
NOESY
5.0
pH
1
atm
303
K
REFINEMENT DETAILS CAN BE FOUND IN THE JOURNAL CITATION.
simulated annealing
BRUNGER
refinement
X-PLOR
structure solution
X-PLOR
600
Varian
UNITY
LEU
1
n
1
LEU
1
A
GLY
2
n
2
GLY
2
A
ALA
3
n
3
ALA
3
A
SER
4
n
4
SER
4
A
TRP
5
n
5
TRP
5
A
HIS
6
n
6
HIS
6
A
ARG
7
n
7
ARG
7
A
PRO
8
n
8
PRO
8
A
ASP
9
n
9
ASP
9
A
LYS
10
n
10
LYS
10
A
CYS
11
n
11
CYS
11
A
CYS
12
n
12
CYS
12
A
LEU
13
n
13
LEU
13
A
GLY
14
n
14
GLY
14
A
TYR
15
n
15
TYR
15
A
GLN
16
n
16
GLN
16
A
LYS
17
n
17
LYS
17
A
ARG
18
n
18
ARG
18
A
PRO
19
n
19
PRO
19
A
LEU
20
n
20
LEU
20
A
PRO
21
n
21
PRO
21
A
GLN
22
n
22
GLN
22
A
VAL
23
n
23
VAL
23
A
LEU
24
n
24
LEU
24
A
LEU
25
n
25
LEU
25
A
SER
26
n
26
SER
26
A
SER
27
n
27
SER
27
A
TRP
28
n
28
TRP
28
A
TYR
29
n
29
TYR
29
A
PRO
30
n
30
PRO
30
A
THR
31
n
31
THR
31
A
SER
32
n
32
SER
32
A
GLN
33
n
33
GLN
33
A
LEU
34
n
34
LEU
34
A
CYS
35
n
35
CYS
35
A
SER
36
n
36
SER
36
A
LYS
37
n
37
LYS
37
A
PRO
38
n
38
PRO
38
A
GLY
39
n
39
GLY
39
A
VAL
40
n
40
VAL
40
A
ILE
41
n
41
ILE
41
A
PHE
42
n
42
PHE
42
A
LEU
43
n
43
LEU
43
A
THR
44
n
44
THR
44
A
LYS
45
n
45
LYS
45
A
ARG
46
n
46
ARG
46
A
GLY
47
n
47
GLY
47
A
ARG
48
n
48
ARG
48
A
GLN
49
n
49
GLN
49
A
VAL
50
n
50
VAL
50
A
CYS
51
n
51
CYS
51
A
ALA
52
n
52
ALA
52
A
ASP
53
n
53
ASP
53
A
LYS
54
n
54
LYS
54
A
SER
55
n
55
SER
55
A
LYS
56
n
56
LYS
56
A
ASP
57
n
57
ASP
57
A
TRP
58
n
58
TRP
58
A
VAL
59
n
59
VAL
59
A
LYS
60
n
60
LYS
60
A
LYS
61
n
61
LYS
61
A
LEU
62
n
62
LEU
62
A
MET
63
n
63
MET
63
A
GLN
64
n
64
GLN
64
A
GLN
65
n
65
GLN
65
A
LEU
66
n
66
LEU
66
A
PRO
67
n
67
PRO
67
A
VAL
68
n
68
VAL
68
A
THR
69
n
69
THR
69
A
ALA
70
n
70
ALA
70
A
ARG
71
n
71
ARG
71
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
SER
27
A
O
SER
27
A
N
LEU
43
A
N
LEU
43
A
O
VAL
40
A
O
VAL
40
A
N
ALA
52
A
N
ALA
52
1
A
A
O
H
LEU
LEU
62
66
1.54
1
A
A
O
H
PRO
LYS
8
10
1.56
1
A
ASP
9
-66.50
61.37
1
A
CYS
12
-38.06
120.68
1
A
LYS
17
87.42
-16.58
1
A
SER
26
-115.48
-71.79
1
A
SER
27
-147.62
-158.91
1
A
LEU
34
-88.07
46.61
1
A
LYS
37
-170.05
71.99
1
A
LYS
56
-52.42
-169.23
1
A
PRO
67
-80.01
-91.59
1
A
VAL
68
172.18
144.30
VIRAL MACROPHAGE INFLAMMATORY PROTEIN-II
MINIMIZED AVERAGE
NMR solution structure of vMIP-II 1-71 from Kaposi's sarcoma-associated herpesvirus (minimized average structure).
1
N
N
A
ALA
3
A
ALA
3
HELX_P
A
ARG
7
A
ARG
7
5
1
5
A
ASP
57
A
ASP
57
HELX_P
A
LEU
66
A
LEU
66
1
2
10
disulf
2.020
A
CYS
11
A
SG
CYS
11
1_555
A
CYS
35
A
SG
CYS
35
1_555
disulf
2.021
A
CYS
12
A
SG
CYS
12
1_555
A
CYS
51
A
SG
CYS
51
1_555
CHEMOKINE
CHEMOKINE, CXCR4, ANATAGONIST, VMIP-II
VMI2_KSHV
UNP
1
Q98157
24
94
1HFG
1
71
Q98157
A
1
1
71
3
anti-parallel
anti-parallel
A
SER
27
A
SER
27
A
PRO
30
A
PRO
30
A
VAL
40
A
VAL
40
A
LEU
43
A
LEU
43
A
GLN
49
A
GLN
49
A
ALA
52
A
ALA
52
1
P 1